A
placebo-controlled study of pyritinol in dementia.
Cooper AJ, Magnus RV.
Pharmatherapeutica 1980;2(5):317-22
ABSTRACT
A double-blind, placebo-controlled
trial was carried out on 40 patients suffering from moderately advanced
dementia. The patients were allocated randomly either pyritinol (800 mg daily)
or identical placebo for 3 months. Assessments using a modified Crichton
Geriatric Behavioural Rating Scale were made pre-treatment and monthly up to 3
months, and then at follow-up at 6 months. Patients on pyritinol showed
significantly higher levels of improvement than did those on placebo.
Laboratory tests conducted throughout remained within normal limits for both
groups.
Galantamine
|
|
Idebenone |
Vinpocetine |
Deprenyl
Piracetam | Picamilon | CDP
Choline |
stroke
|
cataract
Home | Order
|
www.AlzheimersTreatments.com
